Table 2.
Tumor associated antigens and peptide sequences
| Antigen [Ref.] | Peptide sequence and HLA restriction | |
|---|---|---|
| HLA-A24 | HLA-A02 | |
| SART1 [47] | SART1-690 (EYRGFTQDF) | |
| SART2 [34] | SART2-93 (DYSARWNEI) | |
| SART2-161 (AYDFLYNYL) | ||
| SART2-899 (SYTRLFLIL) | ||
| SART3 [51] | SART3-109 (VYDYNCHVDL) | SART3-302 (LLQAEAPRL) |
| SART3-315 (AYIDFEMKI) | SART3-309 (RLAEYQAYI) | |
| CypB [13] | CypB-84 (KFHRVIKDF) | CypB-129 (KLKHYGPGWV) |
| CypB-91 (DFMIQGGDF) | CypB-172 (VLEGMEVV) | |
| lck [16] | lck-208 (HYTNASDGL) | lck-246 (KLVERLGAA) |
| lck-486 (TFDYLRSVL) | lck-422 (DVWSFGILL) | |
| lck-488 (DYLRSVLEDF) | ||
| ART-1 [38] | ART1-170 (EYCLKFTKL) | |
| ART-4 [19] | ART4-13 (AFLRHAAL) | |
| ART4-75 (DYPSLSATDI) | ||
| EIF-4EBP [45] | EIF-4EBP-51 (RIIYDRKFL) | |
| ppMAPkkk [17] | ppMAPkkk-294 (GLLFLHTRT) | |
| ppMAPkkk-432 (DLLSHAFFA) | ||
| WHSC2 [27] | WHSC2-103 (ASLDSDPWV) | |
| WHSC2-141 (ILGELREKV) | ||
| UBE2V [17] | UBE2V-43 (RLQEWCSVI) | |
| UBE2V-85 (LIADFLSGL) | ||
| UBE2V-208 (ILPRKHHRI) | ||
| HNRPL [17] | HNRPL-140 (ALVEFEDVL) | |
| HNRPL-501 (NVLHFFNAPL) | ||
SART squamous cell carcinoma antigen recognized by T cells, CypB cyclophilin B, lck leukocyte-specific protein tyrosine kinase, ART adenocarcinoma antigen recognized by T cells, EIF-4EBP eukaryotic translation Initiation factor-4E binding protein, ppMAPkkk partial putative mitogen-activated protein kinase kinase kinase, WHSC2 Wolf-Hirschhorn syndrome candidate 2 protein, UBE2V ubiquitin-conjugating enzyme variant kua, HNRPL heterogeneous nuclear ribonucleoprotein L